Skip to content

IDENTIFICATION OF HIGH HEMOGLOBIN LEVELS AS A RISK FACTOR AMONG THE PREGNANT WOMEN HAVING HIGH BLOOD SUGAR LEVELS

A STUDY TO INVESTIGATE THE ELEVATED MATERNAL HEMOGLOBIN VALUE AS A RISK BIOMARKER FOR GESTATIONAL DIABETES: A RETROSPECTIVE COHORT STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033387
Enrollment
216
Registered
2021-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O992- Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: NIL: NIL

Sponsors

JSS COLLEGE OF PHARMACY OOTY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Maternal age: 18 years to 40 years Women with a singleton pregnancy Gestation period: 13th week to 28th week (pregnant women of second trimester) Patient taking Routine treatment (Folic acid 0.5mg + FeSo4 335mg (100 mg of elemental iron) OD in the morning 2. Calcium 500 mg OD in the noon 3. Vitamin b complex (vitB1 2mg, vit B2 2mg, vit B6 0.5mg, Niacinamide 25mg Calcium Pantothenate 1mg ) daily during gestational period. The patient will be screened for hemoglobin levels, Fasting blood glucose, postprandial blood glucose, and Random blood glucose and Oral glucose tolerance test.

Exclusion criteria

Exclusion criteria: Chronic hypertension, kidney and liver diseases, pre-pregnancy diabetes mellitus, immunological and inflammatory diseases, thromboembolism, and chronic or active infections. Cardiac diseases, thyroid abnormalities, and known peptic ulcers, esophagitis, gastritis, or hiatus hernia. History of high-risk pregnancy including abruption placenta, placenta previa, coagulation disorders, thrombocytopenia, or history of drug abuse. Previous stillborn fetus.

Design outcomes

Primary

MeasureTime frame
To evaluate whether elevated Hemoglobin level is associated as a risk factor of developing GDM in comparison with normal levels of Hemoglobin among women attending the antenatal check at Government Medical College and Hospital, Ooty.Timepoint: 6 months

Secondary

MeasureTime frame
To assess other blood parameters those, influence the risk of developing GDM.Timepoint: 6 months

Countries

India

Contacts

Public ContactMARIA ADIL KHAN

JSS COLLEGE OF PHARMACY OOTY

roopabs@jssuni.edu.in9047155003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026